152684-24-7

Basic information

• Product Name: ethyl (5-broMopyridin-3-yl)carbaMate
• Synonyms: ethyl (5-broMopyridin-3-yl)carbaMate;(5-Bromo-pyridin-3-yl)-carbamic acid ethyl ester
• CAS NO: 152684-24-7
• Molecular Formula: C₈H₉BrN₂O₂
• Molecular Weight: 245.07326
• Mol File: 152684-24-7.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl (5-broMopyridin-3-yl)carbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (5-broMopyridin-3-yl)carbaMate(152684-24-7)
• EPA Substance Registry System: ethyl (5-broMopyridin-3-yl)carbaMate(152684-24-7)

Safety Data

• Hazardous Substances Data: 152684-24-7(Hazardous Substances Data)

Upstream product

• 20826-04-4 5-bromo-3-pyridinecarboxylic acid 
• 121-44-8 triethylamine 
• 13535-01-8 3-amino-5-bromopyridine 
• 541-41-3 chloroformic acid ethyl ester 
• 64-17-5 ethanol 
• 112193-42-7 (5-bromo-3-pyridyl)carbonyl azide 

Downstream Products

• 152684-25-8 3-bromo-5-(ethoxycarbonyl)amino-2-nitropyridine 
• 1097196-50-3 C₁₁H₉N₃O₂ 
• 1609389-83-4 C₃₀H₃₀N₆O₅ 
• 1609389-84-5 C₂₅H₂₂N₆O₃ 
• 1609389-26-5 N-(2-amino-5-phenylpyridin-3-yl)-7-(piperazin-1-yl)quinoline-3-carboxamide 
• 152684-14-5 3-methylamino-2-nitro-5-phenylpyridine 
• 105650-23-5 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine 
• 433226-11-0 methyl (6-(4-aminophenoxy)-3,4-diazaindole-2-yl)carbamate 
• 433226-40-5 methyl (5-(4-(tert-butoxycarbonyl)aminophenoxy)-3,7-diazaindole-2-yl)carbamate 
• 433226-08-5 2-nitro-5-(4-(tert-butoxycarbonylamino)phenoxy)pyridine-3-ylamine 
• 433226-05-2 5-bromo-2-nitropyridine-3-ylamine 
• 1476730-34-3 5-methoxy-2-nitropyridin-3-amine 

Relevant articles and documents

HETERO-HALO INHIBITORS OF HISTONE DEACETYLASE

This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula I, II or any of Compounds 100-128 or any of those in Tables 2 or 3) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.

NITROGENATED HETEROCYCLIC COMPOUND

The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

SELECTIVE HDAC1 AND HDAC2 INHIBITORS

Provided herein are compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with HDAC activity, particularly diseases or disorders that involve activity of HDAC1 and/or HDAC2. Such diseases include cancer, sickle-cell anemia, beta-thalassemia, and HIV.